Aggrilek Infusion
Marketer
J B Chemicals and Pharmaceuticals Ltd
Salt Composition
Tirofiban (5mg)
Overview Aggrilek Infusion
CardioProtect Infusion is an anticoagulant that inhibits the development of dangerous blood clots. It aids in preventing myocardial infarction in patients experiencing acute chest pain resulting from reduced cardiac blood flow. CardioProtect Infusion is administered under strict medical supervision. Dosage and treatment length will be determined by your physician. Continue all other prescribed medications as directed, even after receiving this infusion. Potential side effects include headache, hematoma, nausea, bruising, post-surgical bleeding, and blood in urine or feces. Report any petechiae or blood in vomit, urine, or stool immediately to your doctor. This medication requires cautious use in certain individuals. Before administration, disclose any bleeding disorders, renal or hepatic impairment, breastfeeding status, and all other current medications to your physician.
Primary Ingredients of Aggrilek Infusion
No information provided. Please provide the text you wish me to rephrase.
Uses of Aggrilek Infusion
Avoiding a Heart Attack
Major Benefits of Aggrilek Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Aggrilek Infusion:
- Headache
- Nausea
- Hematoma
- Ecchymosis (discoloration of the skin resulting from bleeding underneath)
- Postoperative bleeding
- Blood in stool
- Blood in urine
How to use Aggrilek Infusion:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Aggrilek Infusion works:
Aggrilek Infusion is a drug that inhibits platelet aggregation. Its mechanism of action prevents platelet adhesion, thus reducing the risk of dangerous thrombus formation. This, in turn, minimizes the likelihood of cardiac infarction or cerebrovascular accident.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Aggrilek Infusion may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The use of Aggrilek Infusion during pregnancy is generally deemed safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
The administration of Aggrilek Infusion to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingNOT RELEVANT
Aggrilek Infusion is solely for inpatient administration.
KidneyCAUTION
Patients with kidney impairment should receive Aggrilek Infusion with close monitoring. Dosage modification of Aggrilek Infusion may be necessary. Physician consultation is advised.
LiverCAUTION
Aggrilek Infusion requires careful administration in individuals with hepatic impairment. Dosage modification of Aggrilek Infusion may be necessary. Physician consultation is advised. Aggrilek Infusion is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Aggrilek Infusion :
Omitting a scheduled dose of Aggrilek Infusion necessitates contacting your physician.
Facts to Know About Aggrilek Infusion
| Label | Value |
|---|---|
| Chemical Classification | Phenylalanine-based compounds |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Class | IIb/IIIa receptor antagonists |
3,018 People bought this recently